Skip to content

Migraine and Body Composition

Migraine and Body Composition

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01720862
Enrollment
300
Registered
2012-11-02
Start date
2012-04-30
Completion date
2015-10-31
Last updated
2016-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Migraine, Healthy Controls, Migraine With and Without Aura

Keywords

migraine, episodic migraine, chronic migraine, obesity, non-obese

Brief summary

This research is being done to look at the association between migraine and obesity.

Detailed description

Research into the role of inflammatory markers and other obesity related proteins and chemicals may help us understand migraine and lead to new treatment.

Interventions

None listed

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Premenopausal women (18-55 years) * Normal weight (BMI = 18.5 - 24.9) or obese (BMI ≥ 30) * Diagnosis of episodic or chronic migraine or pain free control

Exclusion criteria

* Evidence of pain disorder other than migraine (e.g. irritable bowel syndrome) * Chronic conditions known to alter risk or pattern of migraine (e.g. hypothyroidism) * Illnesses that may affect adipokine levels (e.g. diabetes) * Clinically relevant abnormal glucose/cholesterol levels * Pregnant women * Potential participants who are unable to undergo MRI based on standard screening questionnaire (those with brain aneurysm or surgical clips, certain types of artificial heart valves, heart defibrillator or pacemaker, cochlear implants, eye implants, blood vessel coil, recently placed artificial joints, certain types of vascular stents, history of bullets, pellets, BBs, history of any implanted metal or device or who have worked with sheet metal in the past)

Design outcomes

Primary

MeasureTime frameDescription
association between migraine and obesity - evaluate serum adipokine levels5 yearsThe first aim of the proposed research is to evaluate serum adipokine levels in a clinical cohort of obese and non-obese episodic and chronic migraineurs and examine their utility as markers of the presence or absence of migraine and their relationship to headache frequency.

Secondary

MeasureTime frameDescription
association between migraine and obesity -evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT)five yearsThe second aim of the proposed research is to evaluate subcutaneous adipose tissue (SAT) and its ratio to visceral adipose tissue (VAT),in the same clinical cohort of migraineurs to determine if regional adipose tissue differences exist between: (1) episodic migraineurs, (2) chronic migraineurs and (3) controls, thus contributing to the migraine-obesity relationship.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026